@jzbos

Blood, clotting, Red Sox, repeat. Chief of Hematology Service at Memorial Sloan Kettering Cancer Center #MSKCC

 New York, USA
Joined March 2011
  • Tweets260
  • Following763
  • Followers546
23Media
A #MachineLearning model based on 11 plasma protein markers predicts the risk of #thrombosis in patients with #cancer more accurately than standard risk scores, and uncovers IL-17A as a potential therapeutic target. @jzbos @ioavlachos @BIDMChealth scim.ag/4vkCkZO
3
9
1,042
🚨 Thromboinflammation of cancer In an international collaboration, we identified a limited panel of proteins that predicted thrombosis in cancer. The primary hit was a protein that uncovered an IL-17a mediated endothelial activation pathway. science.org/doi/10.1126/scit…

Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable...

Plasma proteomics improves thrombosis prediction in cancer and uncovers a targetable CD200R1/IL-17–driven endothelial activation pathway in mice.

science.org
1
4
8
682
@rushadpatell @MarcCarrier1 @PhilWellsMD1 @ioavlachos @joythitac @MSK_DeptOfMed @HemeThrombBIDMC
1
1
1
141
@AnnaFalanga19
78
Jeff Zwicker, MD retweeted
Alok Khorana, MD@aakoncApr 17
Excited for the opening of the 13th edition of @ICTHIC @icthicmagazine with exciting new data, talks by @MarcCarrier1 @AngLi_MD @aureliendelluc @LeaderAvi @isabellemahe1 @KSanfilippoMD + many others + Karpatkin Memorial Lecture by @jzbos all on day 1 alone!
3
1
14
745
#ASH25: Divyash Shah will present the results of a study assessing the comparative incidence of venous thromboembolism in patients with chemotherapy-induced thrombocytopenia treated with romiplostim. @MSKCancerCenter @ASH_hematology Learn more: bit.ly/3Ks5LH9
3
7
1,074
Tomorrow morning at #ASH25, Varun Iyengar, MD, will present a study evaluating venous thromboembolism risk factors found via genomic profiling cross subtypes of B-cell #lymphoma. @MSKCancerCenter @ASH_hematology #lymsm Learn more: bit.ly/4pucLmc
5
17
1,839
Jeff Zwicker, MD retweeted
Leslie L. Lake
@lesllake27 Oct 2025
🙏 ⁦@jzbos⁩ & ⁦@MSKCancerCenter⁩ for the opportunity to present ⁦@StopTheClot⁩ #VTEadvocacy work today at the benign hematology event-now in its 10th year! Double 🙏 for always including #VTE patients in this world class event! #stoptheclot #MSK #CAT #MASAB
2
4
270
Jeff Zwicker, MD retweeted
Alok Khorana, MD@aakonc19 Jul 2025
Fascinating paper from Chrysaf @jzbos @LeaderAvi @rushadpatell et al suggesting nearly half the rate of VTE in individuals with FXI deficiency and cancer - important clinical mplications as FXI targeting agents are being developed for cancer VTE sciencedirect.com/science/ar…
5
11
484
Jeff Zwicker, MD retweeted
Alok Khorana, MD@aakonc29 Mar 2025
Practice-changing paper in @nejm by @isabellemahe1 @MarcCarrier1 API-CAT team proves that apixaban dose can be reduced after 6mo of anticoag rx with no loss of efficacy and less bleeding. Congrats to the team! nejm.org/doi/full/10.1056/NE…

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism | NEJM

In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and dec...

nejm.org
2
56
5
130
10,982
Hopefully more sane over there… @hemejz.bsky.social
66
We have a great program. Not too late to signup!
Dr. Jodi Mones@DameofCoags9 Oct 2024
Interested in learning more about benign hematology?
4
261
Making plans for ASH attendance? Don’t forget to arrive in time for the Friday Scientific Workshop on Malignancy and Coagulation! Friday Dec 6, 2-5pm. @ASH_hematology @Lbkreuziger hematology.org/meetings/annu…
3
98
Jeff Zwicker, MD retweeted
Marc Carrier
@MarcCarrier123 Jun 2024
Can low level of CD200R1 help to predict cancer/associated thrombosis? ⬇️ CD200R1 is associated with ⬆️ IL17a leading to thrombin generation and vascular inflammation at #ISTH2024 Nice application of machine learning and plasma proteomics! @isth @jzbos @rushadpatell
7
1
22
2,649
Congratulations!!! @MarcCarrier1 @aswolberg
16
187
Alarming cultural insensitivity in Bangkok. 😂
92
Jeff Zwicker, MD retweeted
Med Learning Group@MLG_CME16 Feb 2024
Don't miss out on our NEW CME/CNE Webinar Series! Join experts @aakonc, @TzufeiWang and @jzbos as they guide you through #BestPractices in diagnosing, managing, and preventing VTE in cancer. Learn more: ow.ly/JP8550QCl0m #oncology #CancerPreventionMonth #Healthcare
Updates in the Prevention, Diagnosis, and Management of Venous Thromboembolism in Cancer: Fundamentals of Optimizing Patient Care in Clinical Practice

ALT Updates in the Prevention, Diagnosis, and Management of Venous Thromboembolism in Cancer: Fundamentals of Optimizing Patient Care in Clinical Practice

5
1
7
676
Jeff Zwicker, MD retweeted
JTH@JTHjournal14 Dec 2023
Balancing safety &efficacy of anticoagulation in primary vs. metastatic brain #cancer is nuanced. Meta-analysis + systematic review suggest DOACs > LMWH in primary, but not metastatic, brain tumors. @varun_pdx @ShubhAgrawalMD @rushadpatell @jzbos jthjournal.org/article/S1538…
11
1
27
4,414
Please check out @cywilkinsmd talking about survival outcomes with Romiplostin use in chemotherapy induced thrombocytopenia #ASH23 @MSKCancerCenter @MSK_DeptOfMed @jzbos – at San Diego, CA
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter11 Dec 2023
Join hematologist-oncologist Dr. Cy R. Wilkins (@cywilkinsmd) for an oral session at #ASH23 TODAY at 3:15pm PST. Learn more here: bit.ly/3TmXk1I
1
3
11
2,155
Simon Mantha of the @MSKCancerCenter presented a dynamic risk model for cancer-associated venous thromboembolism that evaluated EHR data from 35K+ pts. This method could optimize outpatient intervention during periods of high thrombotic risk. #ASH23 @jzbos buff.ly/482OryI
1
3
431
Load more